What is the significance of early repolarization on a 12-lead electrocardiogram (ECG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Asymptomatic patients with early repolarization on a 12-lead ECG should be observed without treatment, as recommended by the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 1.

Key Considerations

  • Early repolarization is a common electrocardiographic finding characterized by J-point elevation, concave upward ST-segment elevation, and prominent T waves in two or more contiguous leads.
  • This pattern is typically seen in the precordial leads V2-V5 or the inferior leads II, III, and aVF.
  • Early repolarization is generally considered a benign, normal variant found in 1-13% of the general population, particularly in young, athletic males, and individuals of African descent.

Recommendations

  • Observation without treatment is recommended for asymptomatic patients with early repolarization pattern on ECG 1.
  • An ICD is recommended for patients with early repolarization pattern on ECG and cardiac arrest or sustained VA, if meaningful survival greater than 1 year is expected 1.
  • Genetic testing is not recommended for patients with early repolarization pattern on ECG 1.

Important Differentiating Features

  • Absence of reciprocal ST depression
  • Lack of Q waves
  • Characteristic concave upward ("smiley face") ST elevation rather than the convex or horizontal ST elevation seen in ischemia

Further Evaluation

  • If a patient with early repolarization presents with concerning symptoms like chest pain, syncope, or palpitations, further cardiac evaluation is warranted to rule out underlying pathology.
  • The 2016 scientific statement from the American Heart Association provides a comprehensive review of the literature on early repolarization, but the 2017 AHA/ACC/HRS guideline provides the most up-to-date recommendations for management 1.

From the Research

Early Repolarization on a 12-Lead ECG

  • Early repolarization (ER) pattern on a 12-lead ECG has been associated with an increased risk of sudden cardiac death (SCD) and ventricular fibrillation 2.
  • The prevalence of ER pattern ≥0.1 mV was more common in victims of SCD (14.4%) than in survivors of an acute coronary event (7.9%) 2.
  • ER pattern is characterized by an elevation of the QRS-ST junction in at least 2 inferior or lateral leads, manifested as QRS notching or slurring 2.

Risk Factors and Associations

  • The presence of ER increases the vulnerability to fatal arrhythmia during acute myocardial ischemia 2.
  • Patients with ER pattern and syncope have a higher risk of life-threatening ventricular arrhythmias (VAs) 3.
  • The 5-year incidence of VAs and arrhythmic events presumably responsible for syncope was 4.9% and 11.0%, respectively, in patients with ER pattern and syncope 3.
  • ER pattern is associated with an elevated risk of unexpected death and a decreased risk of cardiac and all-cause death 4.

Clinical Implications

  • Device implantation based on detailed history taking seems to be a reasonable strategy for patients with ER pattern and syncope 3.
  • Implantable cardioverter-defibrillator implantation and isoproterenol are suggested therapies for patients with early repolarization syndrome (ERS) 5.
  • Risk stratification in asymptomatic patients with ER pattern still remains a grey area 5.
  • Specific ER pattern morphologies and location are associated with an adverse prognosis 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.